Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine with e-cigarette for smoking cessation
NCT05994703Phase 2Completed
- Sponsor
- Rose Research Center
- Start
- Oct 2023
- Primary completion
- Oct 2025
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of d-cycloserine in Tobacco Use Disorder (TUD), sponsored by Rose Research Center. Started Oct 2023; status: completed.
02
Drugs
d-cycloserine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT05994703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05994703.